Install
Daily news and insights on the fast-growing longevity market – antiaging, biotech, research, investment, supplements and rejuvenation therapies. First Longevity Limited provides a service to strictly match groups or individuals seeking investment capital with individuals looking to invest. First Longevity Limited does
- 59articles · 30d
- 3+ day agolatest article
- Aug 17, 2026earliest in window
- 95%with images
- 335avg words
- Medical 50
- Health & Wellness 46
- Health 28
- Science & Technology 25
- Science & Nature 8
- Business & Industrial 7
- Economy, Business & Finance 5
- Beauty & Fitness 3
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
GlycanAge teams up with Japan on aging science
3+ day, 20+ hour ago (410+ words) Biological age testing is having a moment, and it has just gained a foothold in one of the world’s most aging-literate markets. GlycanAge, the UK-based company behind a glycan test that measures inflammaging, has signed a memorandum of understanding with…...
Rentosertib puts aging clocks to the clinical test
5+ day, 20+ hour ago (919+ words) Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life. With a keen interest in all things geroscience,…...
New ALS drug data reveal a mitochondrial fix
5+ day, 21+ hour ago (522+ words) Longevity.Technology New ALS drug data reveal a mitochondrial fix Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: NRG Therapeutics unpacks…...
AI hunts new uses for Phase 3 metabolic drug
1+ week, 4+ day ago (523+ words) longevity.technology AI hunts new uses for Phase 3 metabolic drug Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision. Please get in touch if you are interested: THPharm already has…...
Mount Sinai’s $1m XPRIZE bet: reset immune system, slow aging
2+ week, 5+ day ago (549+ words) Part of a ten-part series profiling each of the $101 million XPRIZE Healthspan competition’s Milestone 2 Awardees. Across the series, Longevity.Technology examines the science behind each team’s approach, the trial data supporting it and what stands between them and the competition’s…...
Can we prime skin to regenerate better?
3+ week, 2+ day ago (1228+ words) Regenerative aesthetics increasingly works by persuading the skin to do more of the work itself – stimulating collagen production rather than simply replacing what time, hormones or weight loss have taken away. But there is a potential catch: sending the signal…...
From K-Beauty to K-Longevity: South Korea???s New Health Model | Longevity News Roundup - Week 34, 2026
3+ week, 3+ day ago (114+ words) In this week’s Longevity News Roundup, Phil Newman examines South Korea’s emerging health tourism model, Network Bio’s biological data platform, Utah’s growing longevity economy, GenBio AI’s virtual cell system, and Longevica’s push toward clinical translation. Spotify | Apple Podcast | YouTube What…...
XellSmart scores FDA fast track for Parkinson’s cell therapy
3+ week, 3+ day ago (314+ words) For XellSmart, the decision builds on growing momentum. XS411 has already received permission to enter clinical trials in both China and the United States, while its Phase II registrational study in China has now completed patient enrollment. Parkinson’s affects more than…...
‘The barriers aren’t clinical, they’re structural’
3+ week, 4+ day ago (594+ words) For decades, South Korea’s medical tourism reputation has been closely associated with aesthetics – dermatology, cosmetic procedures and the formidable international reach of K-beauty. Now, another kind of traveler is arriving: one less interested in changing how aging looks than in…...
Halia bets on genetic resilience against Alzheimer’s
3+ week, 6+ day ago (462+ words) Alzheimer’s drug development has long focused on treating the disease once memory problems have already appeared. Halia Therapeutics believes that may simply be too late. At the Alzheimer’s Association International Conference (AAIC) 2026, the Utah-based biotech unveiled new preclinical findings alongside…...